International Journal of Radiation Oncology * Biology * Physics
Volume 76, Issue 4 , Pages 1100-1105 , 15 March 2010

Comparative Survival in Patients With Postresection Recurrent Versus Newly Diagnosed Non–Small-Cell Lung Cancer Treated With Radiotherapy

  • Xu-Wei Cai, M.D.

      Affiliations

    • Department of Radiation Oncology, University of Michigan Medical Center, Ann Arbor, MI
    • Department of Radiation Oncology, Fudan University Cancer Hospital, Shanghai, China
    • Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China
    • ,
  • Lu-Ying Xu, M.D.

      Affiliations

    • Department of Radiation Oncology, University of Michigan Medical Center, Ann Arbor, MI
    • ,
  • Li Wang, M.D., Ph.D.

      Affiliations

    • Department of Radiation Oncology, University of Michigan Medical Center, Ann Arbor, MI
    • ,
  • James A. Hayman, M.D.

      Affiliations

    • Department of Radiation Oncology, University of Michigan Medical Center, Ann Arbor, MI
    • ,
  • Andrew C. Chang, M.D.

      Affiliations

    • Department of Surgery, University of Michigan Medical Center, Ann Arbor, MI
    • ,
  • Allan Pickens, M.D.

      Affiliations

    • Department of Surgery, University of Michigan Medical Center, Ann Arbor, MI
    • ,
  • Kemp B. Cease, M.D.

      Affiliations

    • Department of Internal Medicine, University of Michigan Medical Center, Ann Arbor, MI
    • ,
  • Mark B. Orringer, M.D.

      Affiliations

    • Department of Surgery, University of Michigan Medical Center, Ann Arbor, MI
    • ,
  • Feng-Ming Kong, M.D., Ph.D.

      Affiliations

    • Department of Radiation Oncology, University of Michigan Medical Center, Ann Arbor, MI
    • Ann Arbor Veterans Affairs Health Center, Ann Arbor, MI
    • Corresponding Author InformationReprint requests to: Feng-Ming (Spring) Kong, M.D., Ph.D., Department of Radiation Oncology, University of Michigan Medical Center, UH-B2C490, Box 0010, 1500 E. Medical Center Dr., Ann Arbor, MI 48109. Tel: (734) 936-7810; Fax: (734) 763-7370

Received 1 January 2009 ,Revised 1 March 2009 ,Accepted 11 March 2009.

References 

  1. Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2008. CA Cancer J Clin. 2008;58:71–96
  2. Gilbert S, Reid KR, Lam MY, et al. Who should follow up lung cancer patients after operation?. Ann Thorac Surg. 2000;69:1696–1700
  3. Martini N, Bains MS, Burt ME, et al. Incidence of local recurrence and second primary tumors in resected stage I lung cancer. J Thorac Cardiovasc Surg. 1995;109:120–129
  4. al-Kattan K, Sepsas E, Fountain SW, et al. Disease recurrence after resection for stage I lung cancer. Eur J Cardiothorac Surg. 1997;12:380–384
  5. Battafarano RJ, Piccirillo JF, Meyers BF, et al. Impact of comorbidity on survival after surgical resection in patients with stage I non-small cell lung cancer. J Thorac Cardiovasc Surg. 2002;123:280–287
  6. Gabler A, Liebig S. Reoperation for bronchial carcinoma. Thorax. 1980;35:668–670
  7. Watanabe Y, Shimizu J, Oda M, et al. Second surgical intervention for recurrent and second primary bronchogenic carcinomas. Scand J Thorac Cardiovasc Surg. 1992;26:73–78
  8. Voltolini L, Paladini P, Luzzi L, et al. Iterative surgical resections for local recurrent and second primary bronchogenic carcinoma. Eur J Cardiothorac Surg. 2000;18:529–534
  9. Shaw EG, Brindle JS, Creagan ET, et al. Locally recurrent non–small-cell lung cancer after complete surgical resection. Mayo Clin Proc. 1992;67:1129–1133
  10. Curran WJ, Herbert SH, Stafford PM, et al. Should patients with post-resection locoregional recurrence of lung cancer receive aggressive therapy?. Int J Radiat Oncol Biol Phys. 1992;24:25–30
  11. Leung J, Ball D, Worotniuk T, et al. Survival following radiotherapy for postsurgical locoregional recurrence of non–small-cell lung-cancer. Lung Cancer. 1995;13:121–127
  12. Emami B, Graham MV, Deedy M, et al. Radiation therapy for intrathoracic recurrence of non-small cell lung cancer. Am J Clin Oncol. 1997;20:46–50
  13. Kagami Y, Nishio M, Narimatsu N, et al. Radiotherapy for locoregional recurrent tumors after resection of non-small cell lung cancer. Lung Cancer. 1998;20:31–35
  14. Jeremic B, Shibamoto Y, Milicic B, et al. External beam radiation therapy alone for loco-regional recurrence of non–small-cell lung cancer after complete resection. Lung Cancer. 1999;23:135–142
  15. Foo K, Gebski V, Yeghiaian-Alvandi R, et al. Outcome following radiotherapy for loco-regionally recurrent non–small cell lung cancer. Australas Radiol. 2005;49:108–112
  16. Sugimura H, Nichols FC, Yang P, et al. Survival after recurrent nonsmall-cell lung cancer after complete pulmonary resection. Ann Thorac Surg. 2007;83(408):409–417
  17. Tada T, Fukuda H, Nakagawa K, et al. Non-small cell lung cancer: Radiation therapy for locoregional recurrence after complete resection. Int J Clin Oncol. 2005;10:425–428
  18. Arriagada R, Bergman B, Dunant A, et al. Cisplatin-based adjuvant chemotherapy in patients with completely resected non–small-cell lung cancer. N Engl J Med. 2004;350:351–360
  19. Winton T, Livingston R, Johnson D, et al. Vinorelbine plus cisplatin vs. observation in resected non–small-cell lung cancer. N Engl J Med. 2005;352:2589–2597
  20. Douillard JY, Rosell R, De Lena M, et al. Adjuvant vinorelbine plus cisplatin versus observation in patients with completely resected stage IB-IIIA non–small-cell lung cancer (Adjuvant Navelbine International Trialist Association [ANITA]): A randomised controlled trial. Lancet Oncol. 2006;7:719–727
  21. Dillman RO, Seagren SL, Propert KJ, et al. A randomized trial of induction chemotherapy plus high-dose radiation versus radiation alone in stage III non–small-cell lung cancer. N Engl J Med. 1990;323:940–945
  22. Le Chevalier T, Arriagada R, Quoix E, et al. Radiotherapy alone versus combined chemotherapy and radiotherapy in nonresectable non–small-cell lung cancer: First analysis of a randomized trial in 353 patients. J Natl Cancer Inst. 1991;83:417–423
  23. Dillman RO, Herndon J, Seagren SL, et al. Improved survival in stage III non–small-cell lung cancer: Seven-year follow-up of cancer and leukemia group B (CALGB) 8433 trial. J Natl Cancer Inst. 1996;88:1210–1215
  24. Kim TY, Yang SH, Lee SH, et al. A phase III randomized trial of combined chemoradiotherapy versus radiotherapy alone in locally advanced non–small-cell lung cancer. Am J Clin Oncol. 2002;25:238–243
  25. Furuse K, Fukuoka M, Kawahara M, et al. Phase III study of concurrent versus sequential thoracic radiotherapy in combination with mitomycin, vindesine, and cisplatin in unresectable stage III non–small-cell lung cancer. J Clin Oncol. 1999;17:2692–2699
  26. Socinski MA, Rosenman JG, Halle J, et al. Dose-escalating conformal thoracic radiation therapy with induction and concurrent carboplatin/paclitaxel in unresectable stage IIIA/B nonsmall cell lung carcinoma: A modified phase I/II trial. Cancer. 2001;92:1213–1223

 Conflict of interest: none.

PII: S0360-3016(09)00440-4

doi: 10.1016/j.ijrobp.2009.03.017

International Journal of Radiation Oncology * Biology * Physics
Volume 76, Issue 4 , Pages 1100-1105 , 15 March 2010

Article Tools

* Image Usage & Resolution